CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
conjugated estrogens +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00149604
NCT00149604Phase 2Completed
CompareCT.gov

Modulation of Visceral Fat by Estrogens After Menopause

National Institute on Aging (NIA)·interventional·Posted Sep 8, 2005·Updated Dec 2, 2009

In Brief

A Phase 2 clinical trial evaluating conjugated estrogens, Raloxifene, and 1 other intervention for Postmenopause. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine whether estrogens specifically promote a reduction in fat from abdominal regions during weight loss and/or prevent the accumulation of abdominal fat during weight gain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostmenopause
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 8, 2005
Enrollment StartMar 1, 2000
Primary CompletionFeb 1, 2006
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 20.8 years ago

Interventions

conjugated estrogensdrug

Raloxifenedrug

exercise plus mild caloric restriction for weight lossbehavioral